Fever, an elevation in body temperature beyond the normal range, often indicates an underlying pathophysiological process, usually infection. Despite being a common clinical sign, its management can be complex due to the myriad of potential etiologies. This article aims to provide a comprehensive guide to managing fever in clinical practice.
The first step in managing fever is a thorough clinical assessment to determine the potential cause. This includes a detailed history, physical examination, and appropriate investigations. Key considerations include the patient's age, comorbidities, medication history, and potential exposure to infectious agents.
Diagnostic investigations should be guided by the clinical suspicion. Commonly employed tests include complete blood count, blood cultures, urine analysis, and chest radiographs. In certain scenarios, more specialized investigations like lumbar puncture or computerized tomography may be warranted.
Management of fever largely depends on the underlying cause. Empirical antibiotic therapy may be initiated in suspected bacterial infections, while viral etiologies generally require supportive management. Antipyretics can be used to alleviate discomfort, but their use should be judicious as fever is a natural defense mechanism of the body.
Regular monitoring of the patient's temperature and response to therapy is crucial. Failure to defervesce despite appropriate therapy may suggest an alternative diagnosis or complications. Follow-up visits should be scheduled to reassess the patient and adjust treatment plans as necessary.
Managing fever in clinical practice is a complex process that requires a systematic approach. By understanding the potential etiologies, conducting appropriate investigations, and implementing evidence-based treatment strategies, healthcare professionals can effectively manage this common clinical sign and improve patient outcomes.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation